you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Oct 22, 16:00
2261.00 -9.50 (-0.42%)
Volume
AVERAGE VOLUME
5-Day
24,757
10-Day
22,562
30-Day
17,327
7,129
  • Prev. Close

    2270.50

  • Open Price

    2306.05

  • Bid Price (Qty.)

    2231.70 (1)

  • Offer Price (Qty.)

    2278.80 (1)

NSE Live

Oct 22, 15:56
2279.85 5.75 (0.25%)
Volume
AVERAGE VOLUME
5-Day
260,565
10-Day
213,213
30-Day
242,264
171,109
  • Prev. Close

    2274.10

  • Open Price

    2286.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2279.85 (269)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Ipca Laboratories (in Rs. Cr.) Mar '21 Mar '20 Sep '19 Mar '19 Sep '18  
Net Sales/Income from operations 2,356.14 2,143.86 2,223.57 1,781.40 1,851.75  
Other Operating Income -- -- -- -- --  
Total Income From Operations 2,356.14 2,143.86 2,223.57 1,781.40 1,851.75  
EXPENDITURE  
Consumption of Raw Materials 787.02 721.69 709.41 560.32 537.70  
Purchase of Traded Goods 131.53 104.83 99.82 84.84 83.03  
Increase/Decrease in Stocks -150.07 -118.05 -37.00 -76.48 -29.66  
Power & Fuel -- -- -- -- --  
Employees Cost 467.83 445.60 425.19 353.07 399.17  
Depreciation 96.23 91.54 87.15 84.23 87.65  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 554.36 531.63 569.55 453.28 574.71  
P/L Before Other 469.24 366.62 369.45 322.14 199.15  
Other Income 35.56 30.93 33.76 27.21 27.38  
P/L Before Int. 504.80 397.55 403.21 349.35 226.53  
Interest 3.87 7.27 8.52 11.18 7.31  
P/L Before Exceptional Items & Tax 500.93 390.28 394.69 338.17 219.22  
Exceptional Items -- -- -- -- --  
P/L Before Tax 500.93 390.28 394.69 338.17 219.22  
Tax 89.48 65.89 66.62 68.52 33.96  
P/L After Tax from Ordinary Activities 411.45 324.39 328.07 269.65 185.26  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 411.45 324.39 328.07 269.65 185.26  
Equity Share Capital 25.37 25.27 25.27 25.27 25.27  
Reserves Excluding Revaluation Reserves -- -- 3,389.63 -- 2,847.82  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 32.44 25.67 25.96 -- 14.66  
Diluted EPS -- -- 25.96 -- 14.66  
EPS After Extra Ordinary  
Basic EPS. 32.44 25.67 25.96 -- 14.66  
Diluted EPS. -- -- 25.96 -- 14.66  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited